Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
5
×
indiana blog main
indiana top stories
life sciences
medicare
5
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
eli lilly
cancer
gene therapy
spinal muscular atrophy
startups
amgen
astrazeneca
biogen
bristol-myers squibb
cancer immunotherapy
What
bio
5
×
roundup
alzheimer’s
cancer
ipo
week
allogene
annual
appetite
arena’s
assessed
attention
biotech
black
bounty
bread
butter
buyout
cash
cig
comeback
communities
companies
conference
congress
corner
crispr
deals
delivered
democrats
diabetes
diamond’s
diversity
divided
drug
drugs
elections
eli
esmo
europe
Language
Current search:
medicare
×
bio
×
fda
×
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
